CDC Awards $148 Million Contract for Emergency Diagnostic Test Development
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read More
Search Results for: liver disease
New Program Aims to Fill Long COVID Diagnostic Gap With Validated Tests
PolyBio Research Foundation has launched a $1.35 million program at UCSF to compare and validate diagnostic tests for long COVID, aiming to address the lack of standardized clinical diagnostics in the field.
Read More
CellCarta and Pillar Biosciences Partner to Expand Tumor Profiling for Oncology Trials
The multi-year collaboration combines kitted next-generation sequencing panels with a global laboratory network to improve turnaround times and support diagnostic programs.
Read More
Urine-Based Liquid Biopsy Shows High Sensitivity for Prostate Cancer Detection
A new study validates a machine-learning platform that detects prostate cancer through biochemical patterns in urine samples.
Read More
New Whole Genome and Transcriptome Assay Launches for Myeloid Malignancies
Caris Life Sciences has launched Caris ChromoSeq, a whole genome and transcriptome sequencing assay for myeloid malignancies, designed to consolidate multiple tests into a single workflow with a seven-day turnaround.
Read More